Trial intelligence / Profile preview

TCI Etomidate vs Propofol for Thoracoscopic Mitral Valve Replacement

NCT02644980Phase 4Unknown

Sponsor
Xijing Hospital
Start
Dec 2015
Primary completion
Aug 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of etomidate in mitral valve disease, sponsored by Xijing Hospital. Status: unknown.

02

Drugs

etomidate
03

Conditions

mitral valve disease

Beyond the preview

Go deeper on NCT02644980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02644980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call